Targeted Feedback Reports to Improve Acute Coronary Syndromes (ACS) Care

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Duke University
ClinicalTrials.gov Identifier:
NCT00952250
First received: August 4, 2009
Last updated: December 1, 2011
Last verified: December 2011
  Purpose

This project is designed to examine the impact of tailored feedback on site performance.

The investigators' objective is to evaluate whether a 'personalized and targeted' feedback, education and performance improvement intervention has a greater impact on adherence to recommended guidelines than standard feedback.

The investigators hypothesize that a site-specific report with centrally identified targets for improvement paired with target specific interventions will enable sites to quickly identify and prioritize salient problem areas, have ready access to an analysis of factors that underlie problems, and formulate an effective action plan. The investigators also hypothesize that those hospitals randomized to receive intervention will be more likely to improve their overall performance, as well as their target specific performance, during the period of observation in direct response to activated QI processes.

Outcomes:

The primary outcome is improvement in the overall composite of all metrics eligible for intervention regardless of their selection as targets.

The secondary outcome is improvement in the composite of targeted metrics.

Outcomes will be assessed in all participating sites, and in among relevant performance subgroups (low performers, academic centers, full service, and among medication versus process metrics).


Condition Intervention
Acute Coronary Syndromes
Behavioral: Targeted Feedback Reports
Behavioral: Targeted Feedback Report

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Personalized and Targeted Feedback in the ACTION-Registry-GWTG

Further study details as provided by Duke University:

Primary Outcome Measures:
  • The primary outcome is improvement in the overall composite of all metrics eligible for intervention regardless of their selection as targets. [ Time Frame: 12 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • The secondary outcome is improvement in the composite of targeted metrics. [ Time Frame: 12 months ] [ Designated as safety issue: No ]

Enrollment: 149
Study Start Date: February 2009
Study Completion Date: July 2011
Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Targeted Feedback Reports
Conventional feedback reports
Behavioral: Targeted Feedback Reports
Sites randomized to this arm will receive specialized feedback summarizing their adherence to the guidelines and suggestions on ways to improve performance.
Experimental: Targeted Feedback Report
Report designed to target areas for local hospital-specific improvement.
Behavioral: Targeted Feedback Report
Report designed to target areas for local hospital-specific improvement

  Eligibility

Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • hospitals participating in the ACTION Registry GWTG

Exclusion Criteria:

  • sites with low volume of data submission (< 10 data forms in the past year)
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00952250

Locations
United States, North Carolina
Duke University Health System
Durham, North Carolina, United States, 27705
Sponsors and Collaborators
Duke University
Investigators
Principal Investigator: Karen P Alexander, MD Duke University
  More Information

No publications provided by Duke University

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Duke University
ClinicalTrials.gov Identifier: NCT00952250     History of Changes
Other Study ID Numbers: Pro00010526
Study First Received: August 4, 2009
Last Updated: December 1, 2011
Health Authority: United States: Institutional Review Board

Keywords provided by Duke University:
quality improvement

Additional relevant MeSH terms:
Acute Coronary Syndrome
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Angina Pectoris
Vascular Diseases
Chest Pain
Pain
Signs and Symptoms

ClinicalTrials.gov processed this record on July 28, 2014